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Introduction {#sec005}
============

Policy makers, clinicians, and payers who seek to improve outcomes in health care are focusing on 30-day readmission rates for patients with acute myocardial infarction and those with heart failure.\[[@pone.0170061.ref001]\] Early post-discharge physician follow-up has been promoted as a method of reducing readmission rates.\[[@pone.0170061.ref002]\] However, studies on the relationships between early post-discharge follow-up and patient outcomes for acute myocardial infarction and heart failure are not only rare but also inconclusive. Of only two studies we are aware of on this topic, one showed that discharge from hospitals that have higher early follow-up rates is associated with a reduction in 30-day readmission for heart failure,\[[@pone.0170061.ref003]\] but another did not establish such relationship for acute myocardial infarction.\[[@pone.0170061.ref004]\] Moreover, to our knowledge, no study has examined whether early follow-up with the same physician or with a cardiologist is associated with lower 30-day readmission for patients with acute myocardial infarction and those with heart failure.

Early or timely outpatient follow-up with a physician for further assessment or treatment has been hypothesized to have an effect on reduced readmission among discharged patients with heart failure and those with acute myocardial infarction.\[[@pone.0170061.ref003]--[@pone.0170061.ref007]\] The transition from hospital to home is a period of particularly higher risk. Timely post-discharge follow-up has been suggested as an important component of efforts to optimize transitional care during the high-risk peri-discharge period.\[[@pone.0170061.ref008], [@pone.0170061.ref009]\] With physiological stress and allostatic load derived from hospitalization, the risks in the critical 30-day period after discharge might exist.\[[@pone.0170061.ref010]\] More importantly, the immediate days that follow discharge are also a vulnerable period owing to the additional therapies or changes in existing medical therapy that may worsen patient outcomes.\[[@pone.0170061.ref003], [@pone.0170061.ref011]\] Seven-day follow-up with the physicians may have the benefit of improving patient outcomes through providing clinical interventions on disease instability (such as diagnostic testing and medication changes),\[[@pone.0170061.ref012]\] and 7-day follow-up with the same physician (because of physician continuity) or with a specialist (because of physician specialty) may be associated with better outcomes than follow-up with other physicians.\[[@pone.0170061.ref003], [@pone.0170061.ref004]\] However, few studies have examined the relationship between 7-day physician follow-up and patient outcomes.

In Taiwan, the National Health Insurance Administration has been the sole insurer and implemented national health insurance since March 1, 1995. The coverage rate of national health insurance has reached 99.9%, and almost all health care facilities are national health insurance contracted providers. Every enrollee is free to go to any hospital or clinic, and enjoys comprehensive benefits with a low cost-sharing policy (10% coinsurance for inpatient care with a yearly cap of about US\$1700, and a US\$1.7--12.0 copayment for outpatient visits). The National Health Insurance Administration has reimbursed providers mainly on a fee-for-service basis since the beginning of the national health insurance program. The Hospital Readmissions Reduction Program, which, under the Affordable Care Act, requires the Centers for Medicare & Medicaid Services to reduce payments to hospitals with excessive readmission rates regarding acute myocardial infarction and heart failure,\[[@pone.0170061.ref013]\] has not yet been introduced in Taiwan. Therefore, Taiwan's healthcare system provides an excellent opportunity to examine whether early post-discharge follow-up improves patient outcomes for patients with acute myocardial infarction and those with heart failure.

To better understand the relationship between early post-discharge follow-up and patient outcomes, we used nationwide population-based data from Taiwan to examine whether physician follow-up within 7 days of discharge was associated with a reduction in 30-day readmission for patients with acute myocardial infarction and those with heart failure. We also further determined whether early follow-up with the same physician or with a cardiologist was associated with much better patient outcomes.

Methods {#sec006}
=======

Database {#sec007}
--------

In this study, we used the National Health Insurance Research Database, provided by the National Health Insurance Administration and managed by the National Health Research Institutes in Taiwan. The database, which is released annually, consists of the following dimensions: inpatient medical benefit claims, ambulatory care medical benefit claims, pharmaceutical benefit claims, contracted medical care institutions, health professionals in contracted medical care institutions, and beneficiaries. Therefore, the database provides an opportunity to examine the relationship between early post-discharge follow-up and patient outcomes.

Ethical Statement {#sec008}
-----------------

The protocol for this study was approved by the Institutional Review Board of the National Taiwan University Hospital (protocol \# 201601056RINB). The dataset we used in this study was secondary data; all information was de-identified by data owners.

Study Population {#sec009}
----------------

This study included all patients aged 18 years and over who were discharged from general acute care hospitals in 2010, with a principal diagnosis of acute myocardial infarction without ST-segment elevation (International Classification of Diseases, 9th revision, clinical modification \[ICD-9-CM\] code 410.7)\[[@pone.0170061.ref004], [@pone.0170061.ref014]--[@pone.0170061.ref016]\] and heart failure with or without preserved ejection fraction (ICD-9-CM code 428), respectively.\[[@pone.0170061.ref017]--[@pone.0170061.ref020]\] Only the first admission of patients with multiple hospitalizations was included for the same medical condition.\[[@pone.0170061.ref003], [@pone.0170061.ref004]\] We excluded patients who were admitted with the same medical condition during the past 6 years, died in the hospital, were transferred out, left the hospital against medical advice, or were discharged against medical advice in a terminally critical condition.\[[@pone.0170061.ref004], [@pone.0170061.ref021]\]

Measures of Variables {#sec010}
---------------------

### Early follow-up {#sec011}

Early follow-up was defined as whether discharged patients had an outpatient visit with a physician within 7 days after discharge.\[[@pone.0170061.ref003], [@pone.0170061.ref004]\] The length of seven days was selected to be consistent with current efforts to improve transitional care.\[[@pone.0170061.ref022]\] Early follow-up with the same physician was measured as whether discharged patients visited the same physician during the hospitalization and during early follow-up.\[[@pone.0170061.ref003]\] Patients who visit the same physician during the hospitalization and at follow-up are considered to have better continuity of care.\[[@pone.0170061.ref003], [@pone.0170061.ref019]\] Early follow-up with a cardiologist was defined as whether discharged patients visited a cardiologist within 7 days after discharge.\[[@pone.0170061.ref003], [@pone.0170061.ref004]\] To explore whether the combined effect of same physician follow-up and cardiologist follow-up on patient outcomes, the interaction term between same physician follow-up and cardiologist follow-up was also considered.

### Patient and hospital characteristics {#sec012}

The covariates included patient and hospital characteristics. The patient covariates included sex, age, comorbid conditions, medical history, in-hospital treatment (percutaneous coronary intervention use, intensive care unit use, administration of surgical operation), length of stay, baseline medications (aspirin, β-blocker, statin, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker), medications within 7 days of discharge, low income, rural residence, number of hospitalizations during the past year, and number of office visits during the past year.\[[@pone.0170061.ref003], [@pone.0170061.ref004], [@pone.0170061.ref009], [@pone.0170061.ref019], [@pone.0170061.ref023]--[@pone.0170061.ref026]\].

The Charlson-Deyo index was used to quantify patient comorbidities.\[[@pone.0170061.ref027]\] This index is the sum of the weighted scores based on the presence or absence of 17 different medical conditions during the past year and the index hospitalization. A score of 0 means that no comorbid index is present, and higher scores point to a greater burden of comorbidity. In addition, we also measured patients' medical history specially related to cardiovascular conditions during the past year and the index hospitalization, which included cardiac risk factors (hypertension, diabetes mellitus), prior cardiac conditions (myocardial infarction, heart failure, atrial fibrillation or flutter), and medical comorbidities (peripheral vascular disease, renal disease).\[[@pone.0170061.ref028]\] The use of the baseline medications was measured according to whether the medications were prescribed during hospital stays and at discharge. Low income was measured as whether the patient was enrolled as a low-income beneficiary. Rural residence was measured whether the patient lived in a rural area based on previous studies using National Health Insurance Research Database.\[[@pone.0170061.ref029]--[@pone.0170061.ref032]\]

The hospital covariates included hospital volume (low, medium, high), hospital level (academic medical center, regional, district), teaching status (yes/no), and geographic location (Taipei, northern, central, southern, Kao-Ping, eastern). We determined the volume of patients who were treated at hospitals using annual condition-specific volume, and then we divided these "annualized" volumes into tertiles.

### Outcome measures {#sec013}

Our primary outcome was 30-day all-cause readmission, which was defined as any re-hospitalization to any acute care hospital within 30 days from index discharge.\[[@pone.0170061.ref003], [@pone.0170061.ref004]\] Hospital readmissions are regarded as potential indicators of poor care or missed opportunities to better coordinate care.\[[@pone.0170061.ref033], [@pone.0170061.ref034]\] Additionally, readmission is expensive to the health care system and commonly represents a preventable adverse event for patients.\[[@pone.0170061.ref024]\] Secondary outcomes of interest were readmission within 30 days of discharge for cardiovascular cause (primary and secondary ICD-9-CM codes 390--459)\[[@pone.0170061.ref017], [@pone.0170061.ref035]\] and readmission within 30 days of discharge for the same cause as the index hospitalization.

Statistical Analysis {#sec014}
--------------------

We used Cox proportional hazard models with robust sandwich variance estimates and propensity score weighting, adjusted for all patient and hospital characteristics, to examine the association between 7-day physician follow-up and 30-day readmission for acute myocardial infarction and heart failure.\[[@pone.0170061.ref028], [@pone.0170061.ref036]\] Cox proportional hazard models allows us to take into account the length of survival after discharge to avoid the problem that patients with early visit are the most severe ones and then they were less likely to be re-hospitalized because they die more often. The models focused on time from discharge until the first re-hospitalization date during the 30 days of follow-up. Patients were censored on date of death, or 30 days post-discharge, whichever came first. All analyses were adjusted for clustering at the hospital level with the use of robust sandwich variance estimates. We modeled 30-day readmission as a function of 7-day physician follow-up, sex, age, comorbid conditions, medical history, in-hospital treatment, length of stay, baseline medications, low income, rural residence, number of hospitalizations during the past year, number of office visits during the past year, hospital volume, hospital level, teaching status, and geographic location.

Moreover, we used propensity score analyses to reduce the selection bias and the potential baseline differences between the early follow-up and the no early follow-up groups.\[[@pone.0170061.ref009], [@pone.0170061.ref028]\] Propensity scores were computed by modeling a logistic regression model in which the dependent variable was whether the discharged patient had an outpatient visit with a physician within 7 days after discharge. The independent variables were patient sex, age, comorbid conditions, medical history, in-hospital treatment, length of stay, baseline medications, low income, rural residence, number of hospitalizations during the past year, number of office visits during the past year, hospital volume, hospital level, teaching status, and geographic location. Then, each patient was weighted by the inverse propensity score when performing Cox proportional hazard models with robust sandwich variance estimates to reduce the selection bias.\[[@pone.0170061.ref025], [@pone.0170061.ref037]--[@pone.0170061.ref040]\]

Finally, we further used Cox proportional hazard models with robust sandwich variance estimates, adjusted for all patient (including medications after discharge) and hospital characteristics, to examine the individual and combined associations of early same physician and early cardiologist follow-up with 30-day readmission among the early follow-up group. In sensitivity analyses, we changed the definition of early physician follow-up by allowing early follow-up to occur within 14 days after discharge.\[[@pone.0170061.ref003]\] Statistical significance was indicated by a 2-tailed value of P\<0.05. All analyses were performed with SAS version 9.3 (SAS Institute Inc, Cary, NC).

Results {#sec015}
=======

Baseline Characteristics and Outcomes {#sec016}
-------------------------------------

Regarding non-ST-segment-elevation myocardial infarction (NSTEMI), we identified 6596 patients discharged from hospital in 2010. We excluded patients under age 18 (N = 0), and patients who had subsequent admission with NSTEMI (N = 397), or had previous admission with NSTEMI during the past 6 years (N = 249). After exclusions ([Fig 1](#pone.0170061.g001){ref-type="fig"}), the final NSTEMI population included 5008 patients. The final population with heart failure consisted of 13577 patients.

![Flow diagram of patient selection.\
Shown are inclusions and exclusions and the final study cohort. HF indicates heart failure; NSTEMI, non-ST-segment-elevation myocardial infarction.](pone.0170061.g001){#pone.0170061.g001}

[Table 1](#pone.0170061.t001){ref-type="table"} presents these patient characteristics. Among patients with NSTEMI, rates of early follow-up with a physician, with the same physician, and with a cardiologist were 76.7%, 56.1%, and 44.8%, respectively. Among those with heart failure, rates of early follow-up with a physician, with the same physician, and with a cardiologist were 74.9%, 52.9%, and 37.6%, respectively. Thirty-day all-cause readmission rates for patients with NSTEMI and those with heart failure were 19.9% and 23.3%, respectively.

10.1371/journal.pone.0170061.t001

###### Characteristics of the study population.

![](pone.0170061.t001){#pone.0170061.t001g}

                                                      NSTEMI        Heart failure
  --------------------------------------------------- ------------- ---------------
  No. of patients                                     5008(100.0)   13577(100.0)
  Follow-up with a physician                                        
   7-day                                              3841(76.7)    10164(74.9)
   14-day                                             4664(93.1)    12197(89.8)
  Follow-up with the same physician                                 
   7-day                                              2807(56.1)    7178(52.9)
   14-day                                             3614(72.2)    8996(66.3)
  Follow-up with a cardiologist                                     
   7-day                                              2242(44.8)    5103(37.6)
   14-day                                             2862(57.1)    6455(47.5)
  Patient Characteristics                                           
   Male sex                                           3367(67.2)    6824(50.3)
   Age, y                                                           
    18--49                                            520(10.4)     1026(7.6)
    50--64                                            1456(29.1)    2345(17.3)
    65--79                                            1920(38.3)    5058(37.3)
    80+                                               1112(22.2)    5148(37.9)
   Charlson score                                                   
    0--1                                              2181(43.6)    3838(28.3)
    2--3                                              1518(30.3)    4988(36.7)
    4+                                                1309(26.1)    4751(35.0)
   Medical history                                                  
    Hypertension                                      3829(76.5)    10617(78.2)
     No                                               1179(23.5)    2960(21.8)
    Diabetes mellitus                                 2439(48.7)    6194(45.6)
     No                                               2569(51.3)    7383(54.4)
    Myocardial infarction                             650(13.0)     1304(9.6)
     No                                               4358(87.0)    12273(90.4)
    Heart Failure                                     827(16.5)     5930(43.7)
     No                                               4181(83.5)    7647(56.3)
    Atrial fibrillation or flutter                    511(10.2)     3889(28.6)
     No                                               4497(89.8)    9688(71.4)
    Peripheral vascular disease                       182(3.6)      564(4.2)
     No                                               4826(96.4)    13013(95.8)
    Renal disease                                     923(18.4)     2697(19.9)
     No                                               4085(81.6)    10880(80.1)
   In-hospital treatment                                            
    PCI                                               2893(57.8)    458(3.4)
    Intensive care unit use                           4311(86.1)    2969(21.9)
    Surgery use                                       471(9.4)      582(4.3)
   Length of stay, d                                                
    \<5                                               2039(40.7)    5671(41.8)
    6--9                                              1512(30.2)    4366(32.2)
    10+                                               1457(29.1)    3540(26.1)
   Baseline medications                                             
    Aspirin                                           4710(94.0)    6573(48.4)
    β-Blocker                                         3183(63.6)    5268(38.8)
    Statin                                            2961(59.1)    2283(16.8)
    ACEI/ARB                                          3610(72.1)    7995(58.9)
   Medications within 7 days of discharge                           
    Aspirin                                           2590(51.7)    3571(26.3)
    β-Blocker                                         1832(36.6)    3233(23.8)
    Statin                                            1670(33.3)    1292(9.5)
    ACEI/ARB                                          1792(35.8)    4305(31.7)
   Medications within 14 days of discharge                          
    Aspirin                                           3425(68.4)    4637(34.2)
    β-Blocker                                         2450(48.9)    4380(32.3)
    Statin                                            2272(45.4)    1752(12.9)
    ACEI/ARB                                          2403(48.0)    5660(41.7)
   Low income                                         98(2.0)       305(2.2)
   Rural residence                                    1205(24.1)    3687(27.2)
   Number of hospitalizations during the past year                  
    0                                                 3312(66.1)    6935(51.1)
    1                                                 942(18.8)     3344(24.6)
    2+                                                754(15.1)     3298(24.3)
   Number of outpatient visits during the past year                 
    Low                                               1696(33.9)    4610(34.0)
    Medium                                            1648(32.9)    4447(32.8)
    High                                              1664(33.2)    4520(33.3)
  Hospital Characteristics                                          
   Hospital volume                                                  
    Low                                               1685(33.6)    4675(34.4)
    Medium                                            1693(33.8)    4575(33.7)
    High                                              1630(32.5)    4327(31.9)
   Hospital level                                                   
    Academic medical center                           2797(55.9)    4571(33.7)
    Regional                                          2077(41.5)    6984(51.4)
    District                                          134(2.7)      2022(14.9)
   Teaching                                           4939(98.6)    12003(88.4)
   Location                                                         
    Taipei                                            1743(34.8)    4608(33.9)
    Northern                                          581(11.6)     1841(13.6)
    Central                                           799(16.0)     2534(18.7)
    Southern                                          858(17.1)     2054(15.1)
    Kao-Ping                                          855(17.1)     2073(15.3)
    Eastern                                           172(3.4)      467(3.4)
  Patient outcomes                                                  
   30-day readmission                                               
    All-cause                                         998(19.9)     3169(23.3)
    Specific-cause                                                  
     Cardiovascular                                   935(18.7)     2842(20.9)
     Same diagnosis                                   182(3.6)      1983(14.6)

NSTEMI indicates non-ST-segment-elevation myocardial infarction; and PCI, percutaneous coronary intervention.

Associations of Early Follow-Up with Patient and Hospital Characteristics {#sec017}
-------------------------------------------------------------------------

[Table 2](#pone.0170061.t002){ref-type="table"} shows the comparison of the discharges followed by outpatient visits with a physician within 7 days to those without. For NSTEMI, baseline characteristics that differed between the follow-up and the no follow-up groups were medical history (heart failure, atrial fibrillation or flutter),PCI use, length of saty, statin use, number of outpatient visits during the past year, hospital volume, level, and location. For heart failure, baseline characteristics that differed between the follow-up and the no follow-up groups were medical history (hypertension, heart failure), PCI use, length of stay, number of hospitalizations during the past year, number of outpatient visits during the past year, hospital volume, level, teaching status, and location. After propensity score weighting, the two groups for NSTEMI and heart failure were well balanced for the baseline characteristics.

10.1371/journal.pone.0170061.t002

###### Baseline characteristics by early follow-up.

![](pone.0170061.t002){#pone.0170061.t002g}

                                                      NSTEMI   Heart failure                                                                         
  --------------------------------------------------- -------- --------------- --------- ------ ------ ------- ------ ------ --------- ------ ------ -------
  Patient Characteristics                                                                                                                            
   Sex                                                                                                                                               
    Male                                              67.1     67.7            0.701     67.2   66.7   0.602   50.0   51.0   0.312     50.2   49.8   0.495
    Female                                            32.9     32.3                      32.9   33.3           50.0   49.0             49.8   50.2   
   Age, y                                                                                                                                            
    18--49                                            10.3     10.8            0.642     10.4   10.9   0.851   7.3    8.3    0.070     7.6    7.6    0.974
    50--64                                            29.2     28.7                      29.1   28.4           17.2   17.6             17.2   17.0   
    65--79                                            38.7     37.2                      38.3   38.6           37.8   35.7             37.3   37.3   
    80+                                               21.9     23.3                      22.2   22.2           37.8   38.4             37.9   38.1   
   Charlson score                                                                                                                                    
    0--1                                              43.5     43.6            0.214     43.6   43.5   0.996   28.1   28.7   0.796     28.3   28.4   0.796
    2--3                                              29.8     32.0                      30.3   30.4           36.8   36.4             36.8   37.1   
    4+                                                26.7     24.4                      26.2   26.2           35.0   34.8             35.0   34.6   
   Medical history                                                                                                                                   
    Hypertension                                                                                                                                     
     Yes                                              76.8     75.5            0.375     76.5   77.0   0.529   78.7   76.7   0.017     78.2   78.1   0.850
     No                                               23.2     24.5                      23.5   23.0           21.3   23.3             21.8   21.9   
    Diabetes mellitus                                                                                                                                
     Yes                                              48.6     48.9            0.860     48.7   48.7   0.980   45.8   44.9   0.360     45.6   45.4   0.781
     No                                               51.4     51.1                      51.3   51.3           54.2   55.1             54.4   54.6   
    Myocardial infarction                                                                                                                            
     Yes                                              12.7     13.8            0.343     13.0   12.5   0.459   9.3    10.4   0.079     9.6    9.6    0.961
     No                                               87.3     86.2                      87.0   87.5           90.7   89.6             90.4   90.4   
    Heart Failure                                                                                                                                    
     Yes                                              15.6     19.5            0.002     16.5   16.4   0.917   43.0   45.6   0.009     43.7   43.5   0.828
     No                                               84.4     80.5                      83.5   83.6           57.0   54.4             56.3   56.5   
    Atrial fibrillation or flutter                                                                                                                   
     Yes                                              9.7      11.9            0.028     10.2   10.0   0.788   28.8   28.1   0.415     28.7   28.9   0.642
     No                                               90.3     88.1                      89.8   90.0           71.2   71.9             71.3   71.1   
    Peripheral vascular disease                                                                                                                      
     Yes                                              3.7      3.5             0.801     3.6    3.7    0.865   4.1    4.2    0.749     4.2    4.1    0.835
     No                                               96.3     96.5                      96.4   96.3           95.9   95.8             95.9   95.9   
    Renal disease                                                                                                                                    
     Yes                                              18.6     17.9            0.600     18.5   18.6   0.882   19.8   19.9   0.920     19.8   19.5   0.552
     No                                               81.4     82.1                      81.5   81.4           80.2   80.1             80.2   80.5   
   In-hospital treatment                                                                                                                             
    PCI                                                                                                                                              
     Yes                                              59.1     53.3            \<0.001   57.7   57.4   0.748   3.7    2.3    \<0.001   3.4    3.3    0.583
     No                                               40.9     46.7                      42.3   42.6           96.3   97.7             96.6   96.8   
    Intensive care unit use                                                                                                                          
     Yes                                              86.0     86.5            0.670     86.1   86.1   0.934   21.7   22.4   0.398     21.9   21.8   0.966
     No                                               14.0     13.5                      13.9   13.9           78.3   77.6             78.1   78.2   
    Surgery use                                                                                                                                      
     Yes                                              9.5      9.2             0.752     9.4    10.0   0.384   4.2    4.6    0.253     4.3    4.2    0.850
     No                                               90.5     90.8                      90.6   90.0           95.8   95.4             95.7   95.8   
   Length of stay, d                                                                                                                                 
    \<5                                               41.4     38.3            0.043     40.7   40.7   0.993   42.6   39.4   \<0.001   41.8   41.8   0.916
    6--9                                              30.3     29.8                      30.2   30.3           32.5   31.2             32.2   32.4   
    10+                                               28.2     31.9                      29.1   29.0           24.9   29.4             26.1   25.9   
   Baseline medications                                                                                                                              
    Aspirin                                                                                                                                          
     Yes                                              94.4     92.9            0.055     94.1   94.2   0.773   48.5   48.1   0.683     48.4   48.3   0.832
     No                                               5.6      7.1                       5.9    5.8            51.5   51.9             51.6   51.7   
    β-Blocker                                                                                                                                        
     Yes                                              63.8     62.7            0.499     63.6   64.0   0.707   38.7   39.1   0.693     38.8   38.6   0.739
     No                                               36.2     37.3                      36.4   36.0           61.3   60.9             61.2   61.4   
    Statin                                                                                                                                           
     Yes                                              58.3     61.7            0.041     59.1   59.4   0.800   16.8   16.7   0.878     16.8   16.8   0.995
     No                                               41.7     38.3                      40.9   40.6           83.2   83.3             83.2   83.2   
    ACEI/ARB                                                                                                                                         
     Yes                                              71.6     73.8            0.141     72.1   71.6   0.644   58.9   58.9   0.961     58.9   58.6   0.681
     No                                               28.4     26.2                      28.0   28.4           41.1   41.1             41.1   41.4   
   Low income                                                                                                                                        
    Yes                                               1.9      2.1             0.779     2.0    2.1    0.669   2.1    2.6    0.075     2.2    2.2    0.679
    No                                                98.1     97.9                      98.0   97.9           97.9   97.4             97.8   97.8   
   Rural residence                                                                                                                                   
    Yes                                               24.4     23.0            0.317     24.1   23.9   0.872   27.4   26.3   0.184     27.2   27.3   0.776
    No                                                75.6     77.0                      76.0   76.1           72.6   73.7             72.8   72.7   
   Number of hospitalizations during the past year                                                                                                   
    0                                                 66.9     63.8            0.105     66.1   65.6   0.784   52.1   48.1   \<0.001   51.1   51.5   0.798
    1                                                 18.2     20.7                      18.9   19.4           24.5   25.0             24.6   24.5   
    2+                                                14.9     15.5                      15.1   15.0           23.4   26.9             24.3   24.0   
   Number of outpatient visits during the past year                                                                                                  
    Low                                               32.7     37.6            \<0.001   33.8   33.4   0.889   31.9   40.0   \<0.001   33.9   33.9   0.982
    Medium                                            32.0     35.9                      33.0   33.4           32.3   34.0             32.8   32.9   
    High                                              35.3     26.5                      33.2   33.2           35.7   26.0             33.3   33.3   
  Hospital Characteristics                                                                                                                           
   Hospital volume                                                                                                                                   
    Low                                               35.3     28.2            \<0.001   33.7   34.4   0.783   35.5   31.4   \<0.001   34.4   34.3   0.819
    Medium                                            33.9     33.5                      33.8   33.6           33.9   33.2             33.7   34.1   
    High                                              30.8     38.3                      32.5   32.1           30.7   35.4             31.9   31.6   
   Hospital level                                                                                                                                    
    Academic medical center                           53.9     62.4            \<0.001   55.8   55.0   0.742   31.5   40.1   \<0.001   33.7   33.7   0.967
    Regional                                          43.2     35.7                      41.6   42.3           53.0   46.7             51.4   51.3   
    District                                          2.9      1.9                       2.7    2.7            15.5   13.2             14.9   15.0   
   Teaching                                                                                                                                          
    Yes                                               98.5     98.9            0.377     1.4    1.4    0.874   88.1   89.4   0.043     88.4   88.4   0.946
    No                                                1.5      1.1                       98.6   98.6           11.9   10.6             11.6   11.6   
   Location                                                                                                                                          
    Taipei                                            34.0     37.4            \<0.001   34.7   33.8   0.934   32.9   37.0   \<0.001   33.9   33.9   0.997
    Northern                                          10.9     13.9                      11.6   11.6           13.7   13.0             13.5   13.4   
    Central                                           15.2     18.3                      16.0   16.2           18.6   18.7             18.7   18.8   
    Southern                                          18.2     13.5                      17.2   17.8           16.0   12.6             15.1   15.2   
    Kao-Ping                                          18.4     12.9                      17.1   17.3           15.2   15.6             15.3   15.3   
    Eastern                                           3.3      4.0                       3.4    3.3            3.6    3.1              3.4    3.4    

NSTEMI indicates non-ST-segment-elevation myocardial infarction; and PCI, percutaneous coronary intervention.

^a^Based on propensity score weighting.

Associations between Early Follow-Up and 30-Day Readmission {#sec018}
-----------------------------------------------------------

[Table 3](#pone.0170061.t003){ref-type="table"} shows the unadjusted associations of early physician follow-up, and patient and hospital characteristics with 30-day readmission. For each condition, early follow-up with a physician, early follow-up with the same physician, and early follow-up with a cardiologist were associated with reduced 30-day readmission. For two conditions, patient and hospital characteristics associated with 30-day readmission were patient sex, age, comorbid conditions, medical history, in-hospital treatment, length of stay, baseline medications, medications within 7 days of discharge, low income, number of hospitalizations during the past year, number of outpatient visits during the past year, hospital volume, level, and teaching status.

10.1371/journal.pone.0170061.t003

###### 30-day all-cause readmission rates by follow-up and baseline characteristics.
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                                                      NSTEMI   Heart failure          
  --------------------------------------------------- -------- --------------- ------ ---------
  Early follow-up                                                                     
   Yes                                                17.4     \<0.001         20.7   \<0.001
   No                                                 28.3                     31.2   
  Early follow-up with the same physician                                             
   Yes                                                14.4     \<0.001         18.1   \<0.001
   No                                                 27.0                     29.2   
  Early follow-up with a cardiologist                                                 
   Yes                                                15.3     \<0.001         18.1   \<0.001
   No                                                 23.6                     26.5   
  Patient Characteristics                                                             
   Sex                                                                                
    Male                                              18.5     \<0.001         23.8   0.205
    Female                                            22.9                     22.9   
   Age (yr)                                                                           
    18--49                                            11.7     \<0.001         18.4   \<0.001
    50--64                                            16.9                     20.0   
    65--79                                            21.2                     23.3   
    80+                                               25.5                     25.9   
   Charlson score                                                                     
    0--1                                              12.3     \<0.001         17.9   \<0.001
    2--3                                              22.0                     22.0   
    4+                                                30.2                     29.1   
   Medical history                                                                    
    Hypertension                                                                      
     Yes                                              21.1     \<0.001         23.7   0.086
     No                                               16.0                     22.2   
    Diabetes mellitus                                                                 
     Yes                                              24.3     \<0.001         24.8   \<0.001
     No                                               15.8                     22.1   
    Myocardial infarction                                                             
     Yes                                              22.9     0.040           26.5   0.005
     No                                               19.5                     23.0   
    Heart Failure                                                                     
     Yes                                              30.2     \<0.001         25.6   \<0.001
     No                                               17.9                     21.6   
    Atrial fibrillation or flutter                                                    
     Yes                                              24.7     0.005           22.4   0.090
     No                                               19.4                     23.7   
    Peripheral vascular disease                                                       
     Yes                                              25.3     0.066           28.9   0.001
     No                                               19.7                     23.1   
    Renal disease                                                                     
     Yes                                              30.3     \<0.001         28.6   \<0.001
     No                                               17.6                     22.0   
   In-hospital treatment                                                              
    PCI                                                                               
     Yes                                              13.4     \<0.001         17.7   0.004
     No                                               28.8                     23.5   
    Intensive care unit use                                                           
     Yes                                              19.9     0.751           26.3   \<0.001
     No                                               20.4                     22.5   
    Surgery use                                                                       
     Yes                                              27.4     \<0.001         26.5   0.069
     No                                               19.2                     23.2   
   Length of stay (d)                                                                 
    \<5                                               14.4     \<0.001         19.7   \<0.001
    6--9                                              18.8                     22.7   
    10+                                               28.9                     29.9   
   Baseline medications                                                               
    Aspirin                                                                           
     Yes                                              19.5     0.005           22.5   0.028
     No                                               26.2                     24.1   
    β-Blocker                                                                         
     Yes                                              19.2     0.074           21.5   \<0.001
     No                                               21.3                     24.5   
    Statin                                                                            
     Yes                                              17.8     \<0.001         21.5   0.020
     No                                               23.0                     23.7   
    ACEI/ARB                                                                          
     Yes                                              18.9     0.003           21.8   \<0.001
     No                                               22.6                     25.6   
   Medications within 7 days of discharge                                             
    Aspirin                                                                           
     Yes                                              14.4     \<0.001         19.4   \<0.001
     No                                               25.8                     24.8   
    β-Blocker                                                                         
     Yes                                              15.1     \<0.001         18.1   \<0.001
     No                                               22.7                     25.0   
    Statin                                                                            
     Yes                                              13.8     \<0.001         17.0   \<0.001
     No                                               23.0                     24.0   
    ACEI/ARB                                                                          
     Yes                                              15.1     \<0.001         17.1   \<0.001
     No                                               22.6                     26.2   
   Medications within 14 days of discharge                                            
    Aspirin                                                                           
     Yes                                              14.6     \<0.001         19.3   \<0.001
     No                                               31.5                     25.4   
    β-Blocker                                                                         
     Yes                                              15.3     \<0.001         18.1   \<0.001
     No                                               24.4                     25.8   
    Statin                                                                            
     Yes                                              13.8     \<0.001         17.6   \<0.001
     No                                               25.0                     24.2   
    ACEI/ARB                                                                          
     Yes                                              14.6     \<0.001         17.0   \<0.001
     No                                               24.9                     27.8   
   Low income                                                                         
    Yes                                               32.7     0.001           27.9   0.059
    No                                                19.7                     23.2   
   Rural residence                                                                    
    Yes                                               21.2     0.219           23.4   0.876
    No                                                19.5                     23.3   
   Number of hospitalizations during the past year                                    
    0                                                 15.5     \<0.001         18.2   \<0.001
    1                                                 26.0                     23.4   
    2+                                                32.0                     34.0   
   Number of outpatient visits during the past year                                   
    Low                                               14.8     \<0.001         20.3   \<0.001
    Medium                                            19.7                     23.3   
    High                                              25.4                     26.5   
  Hospital Characteristics                                                            
   Hospital volume                                                                    
    Low                                               21.2     0.041           25.5   \<0.001
    Medium                                            20.6                     23.4   
    High                                              17.9                     21.0   
   Hospital level                                                                     
    Academic medical center                           18.0     \<0.001         20.0   \<0.001
    Regional                                          22.0                     24.3   
    District                                          28.4                     27.6   
   Teaching                                                                           
    Yes                                               19.7     0.001           22.9   \<0.001
    No                                                36.2                     26.9   
   Location                                                                           
    Taipei                                            18.1     0.127           22.1   0.134
    Northern                                          19.1                     23.1   
    Central                                           20.3                     24.1   
    Southern                                          22.1                     25.1   
    Kao-Ping                                          21.1                     23.7   
    Eastern                                           23.3                     23.6   

NSTEMI indicates non-ST-segment-elevation myocardial infarction; and PCI, percutaneous coronary intervention.

The results of the series of Cox proportional hazard models with robust sandwich variance estimates and propensity score weighting as provided in [Table 4](#pone.0170061.t004){ref-type="table"} demonstrate the associations between early follow-up and 30-day readmission, after adjustment for patient and hospital characteristics. In model 1, early physician follow-up was associated with a lower hazard ratio of all-cause readmission compared with no early physician follow-up for patients with NSTEMI (hazard ratio \[HR\], 0.47; 95% confidence interval \[CI\], 0.39--0.57), and for patients with heart failure (HR, 0.54; 95% CI, 0.48--0.60). Early physician follow-up was also associated with lower 30-day cardiovascular-cause and same-cause readmission.

10.1371/journal.pone.0170061.t004

###### Adjusted relationships between early physician follow-up and 30-day readmission.

![](pone.0170061.t004){#pone.0170061.t004g}

                                                                              All-cause   Cardiovascular-cause   Same-cause                         
  --------------------------------------------------------------------------- ----------- ---------------------- ------------ -------------- ------ --------------
  NSTEMI                                                                                                                                            
  Model 1: early physician follow-up[^a^](#t004fn002){ref-type="table-fn"}    N = 5008                                                              
   Yes (ref: No)                                                              0.47        (0.39--0.57)           0.48         (0.40--0.57)   0.59   (0.41--0.86)
  Model 2: early physician follow-up[^b^](#t004fn003){ref-type="table-fn"}    N = 3841                                                              
   Same physician follow-up (ref: No)                                         0.56        (0.48--0.65)           0.56         (0.47--0.66)   0.62   (0.38--0.99)
   Cardiologist follow-up (ref: No)                                           0.97        (0.81--1.16)           1.03         (0.86--1.24)   0.81   (0.54--1.23)
  Model 3: 14-Day physician follow-up[^a^](#t004fn002){ref-type="table-fn"}   N = 5008                                                              
   Yes (ref: No)                                                              0.18        (0.14--0.24)           0.20         (0.15--0.26)   0.26   (0.17--0.39)
  Model 4: 14-Day physician follow-up[^b^](#t004fn003){ref-type="table-fn"}   N = 4664                                                              
   Same physician follow-up (ref: No)                                         0.53        (0.44--0.62)           0.51         (0.43--0.61)   0.59   (0.39--0.92)
   Cardiologist follow-up (ref: No)                                           0.85        (0.73--1.00)           0.89         (0.76--1.05)   0.85   (0.58--1.24)
  Heart failure                                                                                                                                     
  Model 1: early physician follow-up[^a^](#t004fn002){ref-type="table-fn"}    N = 13577                                                             
   Yes (ref: No)                                                              0.54        (0.48--0.60)           0.57         (0.51--0.64)   0.59   (0.52--0.66)
  Model 2: early physician follow-up[^b^](#t004fn003){ref-type="table-fn"}    N = 10164                                                             
   Same physician follow-up (ref: No)                                         0.69        (0.62--0.76)           0.69         (0.62--0.76)   0.77   (0.68--0.87)
   Cardiologist follow-up (ref: No)                                           0.94        (0.85--1.04)           0.99         (0.90--1.10)   1.03   (0.91--1.17)
  Model 3: 14-Day physician follow-up[^a^](#t004fn002){ref-type="table-fn"}   N = 13577                                                             
   Yes (ref: No)                                                              0.28        (0.25--0.32)           0.31         (0.27--0.34)   0.32   (0.28--0.36)
  Model 4: 14-Day physician follow-up[^b^](#t004fn003){ref-type="table-fn"}   N = 12197                                                             
   Same physician follow-up (ref: No)                                         0.63        (0.58--0.68)           0.64         (0.59--0.70)   0.71   (0.64--0.80)
   Cardiologist follow-up (ref: No)                                           0.94        (0.86--1.03)           1.00         (0.91--1.09)   1.05   (0.94--1.18)

CI indicates confidence interval; HR, hazard ratio; NSTEMI, non-ST-segment-elevation myocardial infarction; and PCI, percutaneous coronary intervention.

^a^Models included sex, age, comorbid conditions, medical history, in-hospital treatment, length of stay, baseline medications, low income, rural residence, number of hospitalizations during the past year, number of office visits during the past year, hospital volume, level, teaching status, and location, and were weighted by the inverse of a propensity score

^b^Models included sex, age, comorbid conditions, medical history, in-hospital treatment, length of stay, baseline medications, medications within 7(14) days of discharge, low income, rural residence, number of hospitalizations during the past year, number of office visits during the past year, hospital volume, level, teaching status, and location.

To further determine the individual and combined associations of same physician and cardiologist follow-up with 30-day readmission among patients with early follow-up, we did not find the synergistic associations between the effects of same physician and cardiologist follow-up. Therefore, an interaction term between same physician and cardiologist follow-up was removed in model 2. Same physician follow-up was associated with a lower hazard ratio of all-cause readmission compared with different physician follow-up for patients with NSTEMI (HR, 0.56; 95% CI, 0.48--0.65), and for patients with heart failure (HR, 0.69; 95% CI, 0.62--0.76). Same physician follow-up was also associated with lower 30-day cardiovascular-cause and same-cause readmission. The robustness of our primary results were evaluated by sensitivity analysis. Results were similar when we changed the transitional period from 7 days to 14 days.

Discussion {#sec019}
==========

This study was the first research using nationwide population-based data to examine the association between early physician follow-up and 30-day readmission, and the relative association of early same physician and early cardiologist follow-up with 30-day readmission for NSTEMI and heart failure. For each condition, we found that early physician follow-up was associated with decreased 30-day readmission compared with no early physician follow-up. Moreover, early follow-up with the same physician was associated with lower 30-day readmission compared with early follow-up with a different physician.

In Taiwan, about 75% percent of hospitalized patients with NSTEMI and heart failure had an outpatient visit within 7 days of discharge. Most early follow-up care was handled by the same physician who treated the patient during the index hospitalization, and usually by cardiologists. The rates of early physician, early same physician and early cardiologist follow-up in Taiwan were higher than those in the United States (38.3%, 18.1%, and 7.5%, respectively, for heart failure).\[[@pone.0170061.ref003]\] These results are because all hospitals in Taiwan are closed systems and are reimbursed for both inpatient and outpatient services on a fee-for-service basis by the National Health Insurance Administration (NHIA). Thus, physicians only employed by hospitals can be allowed to treat inpatients, and hospitals also use variable pay to encourage staff physicians to provide inpatient and outpatient services. Moreover, clinical guidelines recommend early physician follow-up. Therefore, most hospital physicians not only prescribe a week\'s supply of medicine at discharge, but also schedule a follow-up appointment within 7 days of discharge.

This study had two major findings about the association between early physician follow-up and 30-day readmission for NSTEMI and heart failure. First, we found that early follow-up with any physician was associated with lower 30-day readmission for each condition. This result is consistent with the finding of Hernandez et al.\[[@pone.0170061.ref003]\] Hernandez et al verified the association between hospital-level early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. However, the aggregate group-level (hospital-level) variable may be tapping into a different construct than its individual-level (patient-level) namesake.\[[@pone.0170061.ref041]--[@pone.0170061.ref043]\] Thus, the limitations of using an aggregate measure as a proxy for its individual-level namesake relate not only to measurement errors but also to construct validity, that is, whether it is indeed the same construct that is measured by both variables.\[[@pone.0170061.ref041], [@pone.0170061.ref043], [@pone.0170061.ref044]\]

It also must be noted that at the patient level, the association between time from hospital discharge to outpatient follow-up with a physician and risk of readmission is confounded by severity of illness. Patients who have more severe acute myocardial infarction or heart failure, or who are medically less stable are not only commonly seen sooner after hospital discharge but also at a greater risk of readmission.\[[@pone.0170061.ref003], [@pone.0170061.ref004]\] Therefore, we used a propensity score approach to correct for the selection bias. The use of a propensity score method can help reduce the selection bias and provide more valid analysis results. This study may support current clinical guidelines advocating for patients with heart failure or NSTEMI who have been discharged from hospital to receive early or timely outpatient follow-up with a physician for further assessment or treatment.\[[@pone.0170061.ref005], [@pone.0170061.ref007]\]

Another notable finding was that early same physician follow-up (physician continuity) was associated with a further reduction in 30-day readmission. This finding is consistent with that of van Walraven et al\[[@pone.0170061.ref023]\] and of McAlister et al.\[[@pone.0170061.ref019]\] In Ontario, Canada, Walraven et al found that 30-day follow-up with the same physician, rather than with another physician, was associated with reduced 30-day post-discharge mortality or non-elective readmission for non-elective medical or surgical conditions. In Alberta, Canada, McAlister et al found that 30-day follow-up with a familiar physician was associated with lower 3-month post-discharge mortality or urgent readmission for heart failure compared with no follow-up. Although at discharge disease progression is improved, remission is not achieved. Because of early follow-up with a different physician, if the physician does not know a particular patient's disease progression, their progression could possibly be interpreted as a deterioration requiring readmission.\[[@pone.0170061.ref023]\] Moreover, early same physician follow-up is more likely to early determine therapeutic effectiveness and early identify complications of hospital therapies or procedures due to familiarity with the hospital course. Early evaluation and treatment could avoid more serious subsequent problems leading to readmission.

Some limitations existed in this study. First of all, patients were not assigned randomly. This is an observational and retrospective study; therefore, we cannot assign study subjects randomly. The propensity score weighting was adopted for alleviating selection bias.\[[@pone.0170061.ref025], [@pone.0170061.ref037]--[@pone.0170061.ref040]\] Moreover, although, like other studies using administrative databases, no information on disease severity was available for risk adjustment, we adjusted for patient age, comorbid conditions, intensive care unit use, and surgical operation, which are also important for the adjustment of disease complexity.\[[@pone.0170061.ref009], [@pone.0170061.ref019], [@pone.0170061.ref023]--[@pone.0170061.ref026]\] However, we cannot completely exclude the possibility of unmeasured confounders such as behavioral risk factors. Differences in outcomes between follow-up and non-follow-up groups may be confounded by unmeasured behavioral risk factors that may influence access to care. Second, this study defined early follow-up as an outpatient visit that occurred within 7 days of discharge. The 7-day window has previously been discussed and was chosen according to historical precedent and clinical plausibility.\[[@pone.0170061.ref003], [@pone.0170061.ref004]\] However, we also did a sensitivity analysis examining the association between 14-day follow-up and 30-day readmission.

Finally, in Taiwan, follow-up with a trained and specialized nurse (care manager) is not common until now. This may be because the service is not reimbursed by the NHIA. Based on two related studies, one study regarding discharged patient with heart failure in Northern California, United States finds that early outpatient follow-up with a physician is associated with a lower chance of 30-day readmission, but telephone follow-up with a trained and specialized nurse or pharmacist is not.\[[@pone.0170061.ref045]\] Another study regarding ambulatory patients with heart failure in the Apulia Region of Italy finds that the introduction of care managers into the primary health care system has the potential of reducing readmissions because of the strong partnership between the care manager and the patient and the collaboration between the physician and the care manager.\[[@pone.0170061.ref046]\] Future research needs to examine whether the effect of early follow-up visit with a care manager is the same as that with a physician among discharged patients with heart failure or acute myocardial infarction.

Conclusion {#sec020}
==========

Our national population-based study showed that 7-day physician follow-up was associated with lower 30-day readmission, and physician continuity (7-day same physician follow-up) was associated with much lower 30-day readmission for patients with NSTEMI and those with heart failure. This study may provide evidence in support of guidelines recommending scheduling an early follow-up visit after discharge, and it may provide an evidenced-based approach to improve 30-day readmission following NSTEMI and heart failure.
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